Ignite Creation Date:
2024-05-05 @ 12:05 PM
Last Modification Date:
2024-10-26 @ 9:19 AM
Study NCT ID:
NCT00232999
Status:
COMPLETED
Last Update Posted:
2021-11-12
First Post:
2005-10-04
Brief Title:
EfficacySafety Study of Nebulized IVX-0142 a Novel Antiallergic Drug in Mild Allergic Asthma
Sponsor:
Teva Branded Pharmaceutical Products RD Inc
Organization:
Teva Branded Pharmaceutical Products RD Inc
Key Dates - Follows AllAPIJSON File Order
Start Date:
2005-10
Start Date Type:
None
Primary Completion Date:
2005-12
Primary Completion Date Type:
ACTUAL
Completion Date:
2006-01
Completion Date Type:
ACTUAL
First Submit Date:
2005-10-04
First Submit QC Date:
October 4 2005
Study First Post Date:
2005-10-05
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-11-05
Last Update Post Date:
2021-11-12
Last Update Post Date Type:
ACTUAL